➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Harvard Business School
Medtronic
McKinsey
Johnson and Johnson

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Valeant Luxembourg Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for VALEANT LUXEMBOURG, and what generic and branded alternatives to VALEANT LUXEMBOURG drugs are available?

VALEANT LUXEMBOURG has four approved drugs.



Summary for Valeant Luxembourg
US Patents:0
Tradenames:3
Ingredients:4
NDAs:4

Drugs and US Patents for Valeant Luxembourg

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 RX Yes Yes ⤷  Try it Free ⤷  Try it Free
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
Valeant Luxembourg GRIFULVIN V griseofulvin, microsize TABLET;ORAL 062279-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Valeant Luxembourg

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 5,214,036 ⤷  Try it Free
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 5,283,255 ⤷  Try it Free
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 5,798,349 ⤷  Try it Free
Valeant Luxembourg TARGRETIN bexarotene CAPSULE;ORAL 021055-001 Dec 29, 1999 5,466,861 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for VALEANT LUXEMBOURG drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 75 mg ➤ Subscribe 2011-06-06
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Johnson and Johnson
Colorcon
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.